Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference
- Tuesday, April 27, 2021, 7:16
- Environment
- Add a comment
HOUSTON, April 27, 2021 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today announced that the 52-week results from its pivotal cellulite trial have been accepted for an oral…
About the Author
adminasapcorp has written 39731 stories on this site.